.Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J04A_DrugsForTreatmentOfTuberculosis.J04AB30_Capreomycin.Capreomycin .Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J04A_DrugsForTreatmentOfTuberculosis.J04AB30_Capreomycin.Capreomycin| name: | Capreomycin | |
| ATC code: | J04AB30 | route: | intramuscular |
| compartments: | 1 | |
| dosage: | 1000 | mg |
| volume of distribution: | 0.5 | L |
| clearance: | 1.0 | L/h |
| other parameters in model implementation | ||
Capreomycin is a cyclic peptide antibiotic used for the treatment of multidrug-resistant tuberculosis (MDR-TB), usually as a second-line agent in combination therapy. It is not approved for first-line use, and due to its toxicity and the advent of newer antituberculotic drugs, its use today is limited.
Pharmacokinetic parameters estimated for typical adult patients after a single intramuscular dose.